Paravertebral extramedullary haemopoiesis occurring in a case of congenital dyserythropoietic anaemia type II
Modifying the red cell surface
KSHV/HHV8-associated lymphomas
Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis
Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo
High CD21 expression inhibits internalization of anti-CD19 antibodies and cytotoxicity of an anti-CD19-drug conjugate
Investigation of the interleukin (IL)-4/IL-4 receptor system in promyelocytic leukaemia PLB-985 cells during differentiation toward neutrophil-like phenotype
Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients
Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia
Outcome of haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia in third complete remission
The plant mannose-binding lectin NTL preserves cord blood haematopoietic stem/progenitor cells in long-term culture and enhances their ex vivo expansion
Gene expression and pathway analysis of immune thrombocytopenic purpura
Clinical differences between children and adults with pulmonary hypertension and sickle cell disease
Two natural pregnancies following allogeneic transplantation for Fanconi anaemia
Long-term efficacy and tolerance of rituximab for post-transfusional alloimmune haemolytic anaemia in a thalassaemia patient
Patient heterogeneity in phase II studies of refractory disease in multiple myeloma – the ‘spell’ of the time to first relapse
SHIP-1 protein level and phosphorylation status differs between CLL cells segregated by ZAP-70 expression
Invitation to the 13th Congress of the European Hematology Association (EHA) in Copenhagen on 12–15 June, 2008